Janux Therapeutics Welcomes Dr. William Go as Chief Medical Officer to Guide Next Phase of Immunotherapy Clinical Advancements
Market Chameleon (Mon, 26-Jan 9:03 AM)
Janux Lands $850 Million License Deal with Bristol Myers Squibb—Collaboration to Accelerate Novel Cancer Therapies
Market Chameleon (Thu, 22-Jan 11:21 AM)
Janux Therapeutics Secures Major Collaboration with Bristol Myers Squibb, Unlocking Up to $850 Million in Potential Milestones
Market Chameleon (Thu, 22-Jan 7:35 AM)
